Patient Guide: A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 53 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05631093
Status: ACTIVE_NOT_RECRUITING
Condition: HIV-1 Infection
Phase: PHASE3

Find a Study Location Near You

This study is available at 53 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Los Angeles, California
  • Palm Springs, California
  • San Francisco, California
  • • And 50 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily